Physician profile
Robert W Silverio
NPI 1417968546
$1,522.08
in general payments reported to CMS, 2019-2025
30 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $11.72 · 2022: $197 · 2023: $488 · 2024: $241 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $160.13 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $148.63 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $133.10 | 2024-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $131.17 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $117.82 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $105.13 | 2023-2024 | |
| Daiichi Sankyo INC. | $98.37 | 2019-2025 | Injectafer |
| Organon LLC | $49.20 | 2022-2024 | Nexplanon |
| Shield Therapeutics INC | $46.45 | 2024-2025 | |
| Medtronic, INC. | $46.19 | 2023 | Ligasure |
| Coopersurgical, INC. | $38.00 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $37.72 | 2019 | |
| Exeltis, USA INC. | $36.69 | 2023-2024 | Slynd |
| Sage Therapeutics, LLC | $32.41 | 2025 | Zurzuvae |
| Dynavax Technologies Corporation | $32.38 | 2025 | Heplisav-B |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.19 | 2019-2020 | |
| Meditrina | $28.56 | 2023 | |
| Amag Pharmaceuticals, INC. | $25.01 | 2019 | |
| Mayne Pharma Commercial LLC | $24.42 | 2025 | |
| Mylan Pharmaceuticals INC. | $22.91 | 2022 | |
| Agile Therapeutics, INC. | $22.79 | 2022 | |
| Inari Medical, INC. | $22.08 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Optumhealth Care Solutions, LLC | $20.25 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Biohaven Pharmaceutical Holding Company LTD. | $19.47 | 2022 | |
| Novo Nordisk INC | $17.44 | 2023 | |
| Vertical Pharmaceuticals, LLC | $17.34 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.15 | 2022 | |
| Aspira Women'S Health INC | $15.48 | 2023 | Ova1 |
| Supernus Pharmaceuticals, INC. | $14.41 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Silverio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.